Nasdaq

PRIVIGEN® (Immune Globulin Intravenous (Human), 10% Liquid) Granted Orphan-Drug Designation for the Investigational Treatment of Systemic Sclerosis (SSc)

KING OF PRUSSIA, Pa., Feb. 11, 2020 /PRNewswire/ -- Global biotherapeutics leader CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted Privigen® (Immune Globulin ...
Medical News Today

Privigen (human immunoglobulin g) dosing schedule and details

The prescribed dosage for Privigen (human immunoglobulin g) may vary depending on a person’s individual treatment plan. Other factors, including your specific diagnosis, body weight, and medical ...
Monthly Prescribing Reference

Privigen Approved for Chronic Inflammatory Demyelinating Polyneuropathy

The FDA approval was based on data from two Phase 3 studies, PATH and PRIMA. CSL Behring announced that the Food and Drug Administration (FDA) has approved Privigen (immune globulin intravenous [human ...
Healthline

Privigen Side Effects and Tips for Managing Them

Privigen (human immunoglobulin g) can cause side effects that range from mild to serious. More common side effects include headache and nausea. If side effects from Privigen become difficult to ...
Business Insider

CSL Behring Hosts Symposium on Managing CIDP with Immunoglobulin, Supports 14 Scientific Posters and Two Oral Presentations at the 2018 Peripheral Nerve Society Annual Meeting

KING OF PRUSSIA, Pa., July 20, 2018 /PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced that it will support the presentation of 14 scientific posters at the 2018 annual meeting ...